Professor & Vice-Chair, Medical Director of Orange County and Coastal Regions
City of Hope National Medical Center
Irvine, California, United States
Percy Lee, M.D., FASTRO
Dr. Lee is Professor and system-wide Vice-Chair for Clinical Research in radiation oncology at City of Hope National Medical Center (Los Angeles County, Orange County, Atlanta, Chicago, and Phoenix). In addition, he serves as the Medical Director for Orange County and the Coastal Regions in the Department of Radiation Oncology at City of Hope National Medical Center (City of Hope Orange County, Lennar Foundation Cancer Center in addition to 3 other radiation oncology network sites in the region). Previously, he served as Section Chief for Thoracic Radiation Oncology at MD Anderson Cancer Center (MDACC) from 2019-2022, and Executive Section Chief for the Department of Radiation Oncology at MDACC from 2021-2022. Dr. Lee started his career at UCLA (2008-2019) where he rose to the rank of Professor and Vice Chair for Education for the Department of Radiation. At UCLA, he served as Chief of Thoracic Radiation Oncology, Residency Training Program Director, and Director of the Stereotactic Body Radiation Therapy Program (SBRT), a program he founded in 2008. He is an internationally recognized subject matter expert and thought leader in the clinical applications of SBRT. He has over 220 peer-reviewed publications on the clinical use, evidence for, and application of SBRT in the clinic. Dr. Lee has an international reputation in the treatment of thoracic and GI malignancies. He pioneered novel radiosurgery and SBRT technologies such as MRI-guided radiation therapy in the clinic with more than 55 peer-reviewed publications on this subject. In addition, he is a clinical trialist who is interested in combining novel radiation therapy approaches with new drugs to achieve improved outcomes in thoracic malignancies. He has served on various leadership roles within national organizations such as ASTRO, RSS, ABR, and ARS.
Disclosure information not submitted.
Part II: The Lung Cancer Workroom
Thursday, January 23, 2025
3:30pm – 4:35pm PT
Part III: Interactive Tumor Board
Thursday, January 23, 2025
4:35pm – 5:15pm PT